Contact us
Have a question? Please fill out the form below and we will get back to you shortly

    Industries

    Life Sciences, Pharmaceuticals and Biotech

    Proper patent protection is critical in the Life Sciences, Pharmaceuticals, and Biotech industries, where partnerships, licensing deals, and M&As that are highly reliant on IP rights are prevalent. By creating, securing, and maintaining a strong patent portfolio, we create a competitive edge that grows our clients’ business. 

    Our team consists of highly experienced attorneys with a multidisciplinary technical understanding across a variety of different disciplines, with PhDs in biomedical engineering, biotechnology engineering, chemistry, biology, physics, and chemical engineering. We represent large pharmaceutical and agrochemical corporations with diverse portfolios, as well as research institutes and universities.

    At Luzzatto and Luzzatto, our clients receive the full spectrum of intellectual property and patent services, including IP strategy and advice, patent and trademark procurement, IP portfolio management, patent term extension (PTE), freedom-to-operate advice and opinions, technological and IP due diligence assessments and opinions, data exclusivity advice, IP licenses and agreements, IP dispute management and litigation, and M&As.

    Our practice works in full coordination with the Group’s law firm, regarding copyright and other legal needs of clients in these industries.

    The PTE (Patent Term Extension) team is highly experienced and includes partner-level patent attorneys and litigators, who handle each case knowing that the patent term extension, when granted, may end up being litigated. 

    We have successfully protected patents of breakthrough drugs such as PROZAC and VIAGRA, have obtained several important patent extensions in the field of medicine, and have handled complex and lengthy litigation proceedings. 

    Collectively, we have an in-depth knowledge of the Life Sciences, Pharmaceuticals, and Biotech sector, and the experience required to offer high quality, commercially focused advice regarding the protection and exploitation of IP rights. 

    Our Experts

    Relevant Articles

    INTELLECTUAL PROPERTY LANDSCAPE IN ISRAEL 2023: UNVEILING DEVELOPMENTS AND CHALLENGES
    In 2023, the intellectual property landscape in Israel had to deal with challenges created by the ongoing conflict. Despite these obstacles, interesting developments emerged, particularly in artificial intelligence and security, shaping a compelling trajectory for the year. Overall, it was an exceptionally intriguing year.
    Read more....
    The Luzzatto Group Wins a Landmark Ruling
    Regarding Patent Term Extensions in Israel
    On March 27, 2024, the Israeli District Court in Jerusalem rendered a significant ruling in a Novartis case concerning Patent Term Extensions (PTEs), which has broad implications for pharmaceutical patent owners. The court accepted an appeal against a decision of the Registrar of Patents to revoke a PTE, which establishes the principle that PTEs in Israel are linked to the active ingredient and not to the first pharmaceutical preparation used to file the PTE application.
    Read more....
    FemTech, AgriTech, and FoodTech: Israel’s intellectual property beckons investors – The Life Sciences Lawyer magazine 
    Joshua M. Peck, in discussion with Lilach Luzzatto Shukrun, Head of Engineering and Medical Devices at The Luzzatto Group, reports on the growth in three technology areas that are revolutionizing innovation in Israel.
    Read more....

    This website uses cookies to enhance your visit and provide you with information tailored to your interests. For more information on our use of cookies, please see our Privacy Notice.

    Disagree